- Home
- / Kaleido BioSciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Kaleido BioSciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$4.3 K
2024-10-29
Revenue
$1.1 M
FY, 2021
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|---|
| Revenue | 975.0K | 1.1M | |||
| General and administrative expense | 1.6M | 6.0M | 22.4M | 23.9M | 21.0M |
| Operating expense total | 9.4M | 27.0M | 86.7M | 79.8M | |
| EBIT | (9.4M) | (27.0M) | (86.7M) | (78.9M) | (87.7M) |
| EBIT margin, % | -8089.6% | ||||
| Interest income | 32.0K | 1.7M | 249.0K | 72.0K | |
| Interest expense | 141.0K | 435.0K | 329.0K | ||
| Net Income | (9.7M) | (24.6M) | (86.3M) | (81.6M) |